AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
DEFERIPRONE
4 registrations across 3 African markets— 2 active
Markets with DEFERIPRONE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| FERRIPROX Solution buvable / 100 mg/ml | 🇹🇳Tunisia | APOTEX EUROPE BV | expired | Jul 2012 |
| FERRIPROX Comprimé pelliculé sécable / 500 MG | 🇹🇳Tunisia | APOTEX EUROPE BV | expired | Mar 2003 |
| FERRIPROX COMPRIME PELLICULE SECABLE | 🇲🇦Morocco | — | active | — |
| DEFERIP 500MG GELULE BOITE DE 30 | 🇨🇮Côte d'Ivoire | LABORATOIRE MEDINFAR | active | — |
DEFERIPRONE in Africa — Regulatory Overview
DEFERIPRONE is registered across 3 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Côte d'Ivoire, Morocco. AfricaRegulatory refreshes this data daily from official government sources.
Of the 4 registrations, 2 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.